Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Liabilities and Shareholders Equity (2020 - 2026)

SkinHealth Systems has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $499.8 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 27.11% to $499.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, down 25.73% year-over-year, with the annual reading at $499.8 million for FY2025, 27.11% down from the prior year.
  • Liabilities and Shareholders Equity was $499.8 million for Q4 2025 at SkinHealth Systems, down from $503.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.2 billion in Q4 2021 and troughed at $342.5 million in Q2 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $886.9 million (2023), against an average of $828.8 million.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 227928.9% in 2021 and then dropped 29.34% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.2 billion in 2021, then dropped by 17.7% to $1.0 billion in 2022, then decreased by 7.37% to $929.1 million in 2023, then decreased by 26.2% to $685.7 million in 2024, then decreased by 27.11% to $499.8 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Liabilities and Shareholders Equity are $499.8 million (Q4 2025), $503.6 million (Q3 2025), and $507.6 million (Q2 2025).